diabetes

ViewPoints Interview: Zealand Pharma’s Emmanuel Dulac Shares Insights on Zegalogue for Severe Hypoglycemia in Pediatric and Adult Patients with Diabetes

  • by

In an interview with PharmaShots, Emmanuel Dulac, Pharm.D., Ph.D., President and CEO of Zealand Pharma shares insight on the US FDA’s approval of Zegalogue and its availability in both an auto-injector and a prefilled syringe in June 2021. He also highlighted the importance of approval for… Read More »ViewPoints Interview: Zealand Pharma’s Emmanuel Dulac Shares Insights on Zegalogue for Severe Hypoglycemia in Pediatric and Adult Patients with Diabetes

Keto-based digital diabetes program nets $133M  

  • by

Virta Health, a digital health startup with an app-based coaching program for type 2 diabetes, raised $133 million led by Tiger Global. Unlike other digital health companies, Virta builds its program around a ketogenic diet.

Omada Health Launches the First Virtual Cardiometabolic Clinic for Patients with Diabetes and Hypertension

  • by

Shots: The company has launched the first virtual clinic to guide patients with chronic conditions and helps to improve health and behavior via tracking tools & informational guides for weight management, daily activity levels and more Omada’s platform uses AI to analyze movements and range… Read More »Omada Health Launches the First Virtual Cardiometabolic Clinic for Patients with Diabetes and Hypertension

Medtronic Launches World’s First Extended Insulin Infusion Set to Reduce Burden for People with Diabetes in Europe

  • by

Shots: Medtronic launches a new insulin infusion set that can be worn for up to 7days. The infusion set is compatible with all MiniMed 600 and 700 series insulin pumps The extended infusion set utilizes advanced materials that help in reducing insulin preservative loss and… Read More »Medtronic Launches World’s First Extended Insulin Infusion Set to Reduce Burden for People with Diabetes in Europe

Medtronic Launches World’s First 7-Day Wear Infusion Set to Reduce Burden for People with Diabetes

  • by

What You Should Know: – Medtronic has announced the launch of the world’s first and only infusion set that can be worn for up to seven days (instead of the typical three) in select European countries. The infusion set is responsible for delivering insulin from… Read More »Medtronic Launches World’s First 7-Day Wear Infusion Set to Reduce Burden for People with Diabetes

Zealand’s Zegalogue (dasiglucagon) Receives the US FDA’s Approval for the Treatment of Severe Hypoglycemia

  • by

Shots: The approval is based on efficacy results from P-III studies involve assessing Zegalogue vs PBO in children aged 6-17yrs. and in adults with T1D The study met its 1EPs showed an increase in blood glucose of ≥20 mg/dL within 45 minutes, the median time… Read More »Zealand’s Zegalogue (dasiglucagon) Receives the US FDA’s Approval for the Treatment of Severe Hypoglycemia

Lilly Collaborates with Biolojic to Discover and Develop Antibody Therapies for Diabetes

  • by

Shots: Biolojic to receive ~$121M including development and commercialization milestones and a promissory note that may be convertible into Biolojic equity in future Additionally, Biolojic is eligible to receive royalties on sales of therapies that emerges during the collaboration The collaboration will leverage Biolojic’s AI-based… Read More »Lilly Collaborates with Biolojic to Discover and Develop Antibody Therapies for Diabetes

Innovative, Non-Invasive Technologies Advanced Earlier Detection & Monitoring of Liver Disease

  • by

Jon Gingrich, CEO, Echosens North America Leveraging technological advances to facilitate new ways of engaging patients and integrating non-invasive technology into a liver disease program not only serves to improve individual outcomes and reduce costs but also strengthens the financial performance of health systems and… Read More »Innovative, Non-Invasive Technologies Advanced Earlier Detection & Monitoring of Liver Disease

Humana Taps Vida Health to Power Virtual Diabetes Management for Kentucky’s Medicaid Population

  • by

What You Should Know: –  Humana Healthy Horizons™ in Kentucky announced it has selected Vida Health’s virtual diabetes management program to serve Kentucky’s Medicaid population. – Vida’s diabetes management program achieves lasting results for participants. Because chronic conditions like diabetes, obesity, and hypertension often occur simultaneously,… Read More »Humana Taps Vida Health to Power Virtual Diabetes Management for Kentucky’s Medicaid Population

Cerner, Banner Health, Xealth Partner to Simplify How Clinicians Prescribe Digital Health

  • by

What You Should Know: – Cerner Corporation today announced with Xealth new centralized digital ordering and monitoring for health systems, starting with Banner Health, to foster digital innovation. – Health systems can prescribe digital therapeutics, smartphones, and internet apps directly within the EHR to address… Read More »Cerner, Banner Health, Xealth Partner to Simplify How Clinicians Prescribe Digital Health

Elation Health Nabs $40M for Clinical-First Solution to Power Independent Primary Care

  • by

What You Should Know: – Elation Health, which provides an easy-to-use and affordable clinical technology platform for more than 7 million independent primary care clinicians serving 14M+ patients – including an EHR raises $40M in Series C funding from Al Gore’s sustainable investment firm, Generation… Read More »Elation Health Nabs $40M for Clinical-First Solution to Power Independent Primary Care

Highmark, Lark Health extend collaboration

  • by

The expanded partnership increases the number of Highmark health plan members eligible for enrollment in Lark Health’s AI-driven health coaching programs aimed at managing and preventing chronic diseases.

Abbott’s FreeStyle Libre 2 Receives Health Canada’s Approval for Adults and Children with Diabetes

  • by

Shots: Abbott’s next-generation, sensor-based glucose monitoring technology, FreeStyle Libre 2, received Health Canada’s approval for adults & children with diabetes The system continuously measures glucose data every minute with customizable, optional real-time alarms to alert users when their glucose is high/low without scanning The technology… Read More »Abbott’s FreeStyle Libre 2 Receives Health Canada’s Approval for Adults and Children with Diabetes

Intermountain Adds Omada’s Diabetes Prevention Program to At-Risk Patients

  • by

What You Should Know: – Omada’s diabetes prevention program will be available to Intermountain’s at-risk patient population as part of a limited engagement in 2020 and 2021. – Omada’s diabetes prevention program is personalized to meet each participant’s unique needs as they evolve, ranging from… Read More »Intermountain Adds Omada’s Diabetes Prevention Program to At-Risk Patients

Medtronic Launches InPen Integrated with CGM Data for People with Diabetes on MDI

  • by

Shots: The integration of real-time CGM data into the smart insulin pen app follows the acquisition of Companion Medical’s InPen to the Medtronic portfolio, as of Sept’2020 The integrated system provides real-time glucose readings alongside insulin dose information giving users everything they need to manage… Read More »Medtronic Launches InPen Integrated with CGM Data for People with Diabetes on MDI

4 Ways to Combat Hidden Costs Associated with Delayed Patient Care During COVID-19

  • by

Matt Dickson, VP, Product, Strategy, and Communication Solutions at Stericycle COVID-19 terms such as quarantine, flatten the curve, social distance, and personal protective equipment (PPE) have dominated headlines in recent months, but what hasn’t been discussed in length are the hidden costs of COVID-19 as… Read More »4 Ways to Combat Hidden Costs Associated with Delayed Patient Care During COVID-19

Lark Health raises $70M

  • by

Lark Health, which offers AI-powered digital care platforms for chronic diseases, has raised $70 million in new funds, which it plans to use to expand its relationship with Anthem and eventually deepen partnerships with other payers and telehealth providers.

FDA Grants AppliedVR Breakthrough Designation for Virtual Reality Chronic Pain Treatment

  • by

What You Should Know: – FDA awards AppliedVR Breakthrough Device designation for treating treatment-resistant fibromyalgia and chronic intractable lower back pain – AppliedVR’s EaseVRx program helps patients learn self-management skills grounded in evidence-based cognitive-behavioral therapy (CBT) principles and other behavioral methods. AppliedVR, a pioneer advancing… Read More »FDA Grants AppliedVR Breakthrough Designation for Virtual Reality Chronic Pain Treatment

Sharing rebates can improve access to medicines and increase health equity

  • by

Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Today, we… Read More »Sharing rebates can improve access to medicines and increase health equity

Innovaccer, CareSignal Partner to Enable Deviceless Remote Patient Monitoring

  • by

What You Should Know: – Innovaccer has recently partnered with CareSignal to address healthcare’s urgent need amidst the COVID-19 pandemic: to create and maintain solid, clinically actionable relationships with patients in a new set of predominantly virtual care. – CareSignal offers evidence-based end-to-end support services… Read More »Innovaccer, CareSignal Partner to Enable Deviceless Remote Patient Monitoring

Eli Lilly Reports Results of Jardiance (empagliflozin) in P-III EMPEROR Trial for Heart Failure Patients with Reduced Ejection Fraction with and without Diabetes

  • by

Shots: The P-III EMPEROR Trial involves assessing of Jardiance (10 mg) vs PBO in two studies EMPEROR-Reduced [NCT03057977, N=3,730] & EMPEROR-Preserved [NCT03057951, N=5,990] in patients with HFrEF & HFpEF respectively The EMPEROR-Reduced study meets its 1EPs in reducing the risk for the composite of cardiovascular… Read More »Eli Lilly Reports Results of Jardiance (empagliflozin) in P-III EMPEROR Trial for Heart Failure Patients with Reduced Ejection Fraction with and without Diabetes

Trial shows AZ’s Farxiga slows onset of chronic kidney disease and cuts mortality

  • by

AstraZeneca’s Farxiga could be on course for another use, after trial results showed it slowed the worsening of renal function and cut the risk of death in patients with chronic kidney disease with and without type 2 diabetes. Farxiga (dapagliflozin), an oral once-daily sodium-glucose co-transporter-2… Read More »Trial shows AZ’s Farxiga slows onset of chronic kidney disease and cuts mortality

DarioHealth, Williams Medical Partner to Expand Digital Therapeutics Platform Across the UK and Ireland

  • by

What You Should Know: – Dario Health enters strategic partnership with Williams Medical marking its expansion into the UK remote patient monitoring market across the UK and Ireland. – Williams Medical is the leading provider of medical goods and services to primary care in the… Read More »DarioHealth, Williams Medical Partner to Expand Digital Therapeutics Platform Across the UK and Ireland

New CVS Pharmacy App Feature Can Read Prescription Labels Out Loud for Visually Impaired

What You Should Know: – CVS introduced Spoken Rx™, a new feature of the CVS Pharmacy app that can read important prescription information out loud. It is vitally important for patient safety and adherence that prescription labels are clear and visible, but for patients with visual impairments… Read More »New CVS Pharmacy App Feature Can Read Prescription Labels Out Loud for Visually Impaired

Philips and BioIntelliSense Integrate to Enhance Remote Patient Monitoring

What You Should Know: – Philips integrates the BioIntelliSense FDA-cleared BioSticker™ sensor as part of its remote patient monitoring solutions for patients outside the hospital. – Multi-parameter sensors aid monitoring across multiple chronic conditions with medical-grade vital signs for physicians to remotely track core symptoms,… Read More »Philips and BioIntelliSense Integrate to Enhance Remote Patient Monitoring